Levomepromazine vs Typical antipsychotics
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
Levomepromazine showed no clear difference in leaving the study early ‐ long term ‐ any reason compared with typical antipsychotics (moderate certainty).
1 finding from 1 review
- RR 0.4 [0.09, 1.81]1 study · 38 participantsModerate